Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial

Publication | Closed Access

DOI

Citations

References

2012

Year

Andrew P. Ambrosy, Muthiah Vaduganathan, Robert J. Mentz, Stephen J. Greene, Haris Subačius, Marvin A. Konstam, Aldo P. Maggioni, Karl Swedberg, Mihai Gheorghiade

American Heart Journal

Heart FailureBlood PressureCardiovascular DiseaseAntihypertensive TherapyPrognostic ValueCardiac CareMedicineCardiologyDiastolic FunctionAnesthesiologyVasopressin Antagonism